⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL595356 | 1.00 | — | — | |
| SCHEMBL8037345 | 1.00 | — | — | |
| SCHEMBL176061 | 1.00 | — | — | |
| SCHEMBL822 | 1.00 | — | — | |
| Phosphine SCHEMBL20477183 | 1.00 | — | — | |
| SCHEMBL9177548 | 1.00 | — | — | |
| SCHEMBL1459105 | 0.71 | — | — | |
| SCHEMBL9185475 | 0.71 | — | — | |
| Fluoride SCHEMBL9130872 | 0.71 | — | — | |
| SCHEMBL8204904 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 587 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260062446-A1 | SCALABLE SYNTHESIS OF ANABAENOPEPTINS | WAYNE STATE UNIVERSITY (US) | 2026-03-05 | — | — | US | claimed |
| CN-119988995-A | Ancient biological data identification platform | 中国地质科学院地质研究所 | 2025-05-13 | — | — | CN | claimed |
| CN-119186260-A | Method for replacing oxygen isotopes from carbon monoxide | 中国原子能科学研究院 | 2024-12-27 | — | — | CN | claimed |
| CN-115716661-B | Process for preparing oxygen 16 enriched metal oxides | 中国原子能科学研究院 | 2024-03-22 | — | — | CN | claimed |
| CN-115716661-A | Method for producing oxygen 16-enriched metal oxide | 中国原子能科学研究院 | 2023-02-28 | — | — | CN | claimed |
| EP-4747387-A1 | COAGULATION FACTOR XI-MODULATING COMPOSITIONS AND METHODS OF USE THEREOF | Adarx Pharmaceuticals, Inc. (US) | 2026-05-27 | — | — | EP | disclosed |
| CN-113164489-B | Inhibitors of VAP-1 | ACUCELA INC. (US) | 2026-05-26 | — | — | CN | disclosed |
| EP-3976600-B1 | NON-HYGROSCOPIC CRYSTALLINE SALTS OF A PYRAZOLE COMPOUND, AND PHARMACEUTICAL COMPOSITIONS AND USE THEREOF | YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD (IL) | 2026-05-20 | — | — | EP | disclosed |
| EP-4743118-A1 | FUNCTIONALIZED AURISTATINS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS | Surio Therapeutics Co. Ltd (CN) | 2026-05-20 | — | — | EP | disclosed |
| US-12633426-B2 | Method for determining real-time thermal power of a nuclear reactor based on number of gamma rays counted | MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2026-05-19 | — | — | US | disclosed |
| CN-121578570-B | Method and device for inhibiting ultraviolet laser damage of fused quartz optical element | 中国工程物理研究院激光聚变研究中心 | 2026-05-15 | — | — | CN | disclosed |
| US-20260130928-A1 | COMBINATION OF AKR1C3 ACTIVATED ANTICANCER PRODRUG COMPOUND AND ANALGESIC DRUG FOR TREATING CANCER PATIENTS ACCOMPANIED BY PAIN | ASCENTAWITS PHARMACEUTICALS LTD (CN) | 2026-05-14 | — | — | US | disclosed |
| US-11266651-B2 | Pharmaceutical compositions and methods of treating cardiovascular diseases | CARDIX Therapeutics, LLC (US) | 2022-03-08 | — | — | US | disclosed |
| WO-2022046905-A1 | CRF RECEPTOR ANTAGONISTS AND METHODS OF USE | NEUROCRINE BIOSCIENCES, INC. (US) | 2022-03-03 | — | — | WO | disclosed |
| US-20220056488-A1 | MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF AROMATICS, 2,4-PENTADIENOATE AND 1,3-BUTADIENE | GENOMATICA INC (US) | 2022-02-24 | — | — | US | disclosed |
| US-20220040169-A1 | Methods for the Administration of Certain VMAT2 Inhibitors | NEUROCRINE BIOSCIENCES, INC. | 2022-02-10 | — | — | US | disclosed |
| WO-2022031925-A1 | ULTRA EFFICIENT ACCELERATOR PRODUCTION OF ISOTOPICALLY PURE ACTINIUM-225 | CRYORAD, INC. (US) | 2022-02-10 | — | — | WO | disclosed |
| US-11242352-B2 | Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment of cancer | CAPELLA THERAPEUTICS, INC. (US) | 2022-02-08 | — | — | US | disclosed |
| US-20220024915-A1 | INHIBITORS OF VAP-1 | ACUCELA INC. | 2022-01-27 | — | — | US | disclosed |
| US-7897400-B2 | Non-invasive rapid diagnostic test for M. tuberculosis infection | STC.UNM (US) | 2011-03-01 | — | — | US | disclosed |